Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

203
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
203
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

276
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
276
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

56
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
56
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

467
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
467
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

250
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
250
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Linking land use to the likely origins of third-generation cephalosporin-resistant Enterobacterales in freshwater.

Applied and environmental microbiology·2026
Same author

Generation and Translation of Nursing Science Research Interest and Implementation Group.

Research in nursing & health·2026
Same author

Lessons from the COVID-19 pandemic: A secondary thematic analysis of nurse managers' experiences.

Nursing·2026
Same author

One Woman's Experience of Skin-to-Skin Care With Her Extremely-Low-Birth-Weight Neonate.

Journal of obstetric, gynecologic, and neonatal nursing : JOGNN·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Surgical Intensive Care Unit Nurses' Coping With Moral Distress and Moral Residue: A Descriptive Qualitative Approach.

Dimensions of critical care nursing : DCCN·2025

Related Experiment Video

Updated: Jun 26, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

85.9K

Treatment for Neonatal Abstinence Syndrome Using Nonpharmacological Interventions.

Tonya W Robinson1, Reetta Stikes2, Jaki Sorrell2

  • 1Department of Pediatrics, University of Louisville School of Medicine, Louisville, Kentucky.

American Journal of Perinatology
|May 10, 2024
PubMed
Summary

A study on bassinets for neonatal abstinence syndrome (NAS) found they did not improve outcomes. Infants treated with the special bassinet had longer hospital stays and increased morphine exposure, suggesting further research is needed.

More Related Videos

A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

14.3K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

186

Related Experiment Videos

Last Updated: Jun 26, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

85.9K
A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

14.3K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

186

Area of Science:

  • Neonatal Intensive Care
  • Pharmacology
  • Pediatrics

Background:

  • Neonatal Abstinence Syndrome (NAS) management often includes nonpharmacological interventions.
  • The effectiveness of these interventions, particularly specialized equipment, requires rigorous evaluation.
  • Prenatal opioid exposure is a significant concern in neonatal care.

Purpose of the Study:

  • To evaluate the effectiveness of a specific type of bassinet as a nonpharmacological intervention for infants with NAS.
  • To compare outcomes of infants with NAS managed with and without the specialized bassinet.

Main Methods:

  • Retrospective observational cohort study in a Level III NICU.
  • Inclusion criteria: infants ≥ 35 weeks with prenatal opioid exposure requiring pharmacological treatment.
  • Three groups analyzed: no intervention, nonpharmacological intervention, and specialized bassinet intervention.

Main Results:

  • Infants managed with the specialized bassinet (Group 3) showed significantly increased length of stay compared to both other groups.
  • Group 3 also had a significantly longer treatment duration and higher total morphine exposure than the non-intervention group (Group 1).

Conclusions:

  • The specialized bassinet, used as a nonpharmacological aid for NAS, did not demonstrate benefits.
  • Findings suggest this bassinet may prolong hospital stay, treatment duration, and increase opioid exposure.
  • Further research is warranted before widespread adoption of such devices for routine NAS care.